30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Biora Therapeutics Inc (BIORQ)

Track

Stock chart
Ticker: BIORQ Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Athyrium Opportunities III Co-Invest 1 LP
1 purchase — total 0 USD
Buy 9 Nov 2022
Value US$1,843,479.04 | Price 218.18 | Shares 79,711
Sale 5 Jul 2022
Value US$4,192,044.97 | Price 401.99 | Shares 54,987
Buy 14 Jun 2021
Value US$20,000,000.02 | Price 2.47 | Shares 8,097,166
Buy 14 Jun 2021
Value US$20,000,000.02 | Price 2.47 | Shares 8,097,166
Buy 16 Dec 2020
Value US$104,482.40 | Price 4.40 | Shares 23,746
Buy 16 Dec 2020
Value US$161,374.50 | Price 4.70 | Shares 34,335
Buy 15 Dec 2020
Value US$259,950.90 | Price 4.07 | Shares 63,870
Buy 14 Dec 2020
Value US$97,000.00 | Price 4.85 | Shares 20,000
Buy 7 Dec 2020
Value US$13,499,998.80 | Price 3.27 | Shares 4,128,440
Buy 7 Dec 2020
Value US$13,499,998.80 | Price 3.27 | Shares 4,128,440
Buy 2 Dec 2020
Value US$499,999.35 | Price 3.27 | Shares 152,905
Buy 3 Sep 2020
Value US$78,241.05 | Price 8.55 | Shares 9,151
Buy 2 Sep 2020
Value US$846.45 | Price 8.55 | Shares 99
Buy 19 Aug 2020
Value US$89,400.00 | Price 8.94 | Shares 10,000
Buy 23 Jun 2020
Value US$49,999,995.00 | Price 15.00 | Shares 3,333,333
Buy 23 Jun 2020
Value US$49,999,995.00 | Price 15.00 | Shares 3,333,333
Buy 19 Jun 2020
Value US$499,995.00 | Price 15.00 | Shares 33,333
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-14 2022-11-09 B Purchase
Athyrium Opportunities III Co-Invest 1 LP
Large shareholder
79,711
218.18
US$1,843,479 		79,711 218.18 US$1,843,479
2022-07-05 2022-07-05 S Sale
Sarna Surbhi
Non-Executive Director
54,987 +6.3%
401.99
US$4,192,045 		54,987 +6.3% 401.99 US$4,192,045
2021-06-14 2021-06-14 B Purchase
3.3
Athyrium Opportunities Fund (A) LP
Large shareholder
99,501 +39.5%
468.28
US$1,539,297 		99,501 +39.5% 468.28 US$1,539,297
2021-06-14 2021-06-14 B Purchase
3.3
Athyrium Capital Management, LP
Large shareholder
8,097,166 +28.6%
2.47
US$20,000,000 		8,097,166 +28.6% 2.47 US$20,000,000
2020-12-17 2020-12-16 B Purchase
2.6
Silvestry Damon

Chief Operating Officer

Officer
23,746 +12.0%
4.40
US$104,482 		23,746 +12.0% 4.40 US$104,482
2020-12-17 2020-12-16 B Purchase
2.6
Silvestry Damon

Chief Operating Officer

Officer
34,335 +21.0%
4.70
US$161,374 		34,335 +21.0% 4.70 US$161,374
2020-12-16 2020-12-15 B Purchase
2.6
Silvestry Damon

Chief Operating Officer

Officer
63,870 +64.3%
4.07
US$259,951 		63,870 +64.3% 4.07 US$259,951
2020-12-15 2020-12-14 B Purchase
1.7
Alter Jeffrey D.
Non-Executive Director
20,000 +109.1%
4.85
US$97,000 		20,000 +109.1% 4.85 US$97,000
2020-12-09 2020-12-07 B Purchase
3.3
Athyrium Opportunities Fund (A) LP
Large shareholder
4,128,440 +18.1%
3.27
US$13,499,999 		4,128,440 +18.1% 3.27 US$13,499,999
2020-12-09 2020-12-07 B Purchase
3.3
Athyrium Capital Management, LP
Large shareholder
4,128,440 +18.1%
3.27
US$13,499,999 		4,128,440 +18.1% 3.27 US$13,499,999
2020-12-04 2020-12-02 B Purchase
2.9
Stylli Harry

Chairman & CEO

Executive Director Large shareholder
152,905 +1.1%
3.27
US$499,999 		152,905 +1.1% 3.27 US$499,999
2020-09-04 2020-09-03 B Purchase
1.7
Cooper Matthew T

Chief Scientific Officer

Officer
9,151 +20.7%
8.55
US$78,241 		9,151 +20.7% 8.55 US$78,241
2020-09-04 2020-09-02 B Purchase
1.7
Cooper Matthew T

Chief Scientific Officer

Officer
99 +0.2%
8.55
US$846 		99 +0.2% 8.55 US$846
2020-08-21 2020-08-19 B Purchase
2.9
Stylli Harry

Chairman & CEO

Executive Director Large shareholder
10,000 +0.1%
8.94
US$89,400 		10,000 +0.1% 8.94 US$89,400
2020-06-25 2020-06-23 B Purchase
3.3
Athyrium Capital Management, LP
Large shareholder
3,333,333 +16.7%
15.00
US$49,999,995 		3,333,333 +16.7% 15.00 US$49,999,995
2020-06-25 2020-06-23 B Purchase
3.3
Athyrium Opportunities Fund (A) LP
Large shareholder
3,333,333 +16.7%
15.00
US$49,999,995 		3,333,333 +16.7% 15.00 US$49,999,995
2020-06-23 2020-06-19 B Purchase
2.9
Stylli Harry

Chairman & CEO

Executive Director Large shareholder
33,333 +3.3%
15.00
US$499,995 		33,333 +3.3% 15.00 US$499,995
Explore more

More insider trading research around Biora Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America